SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 72 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $71,000 | +1.4% | 130,698 | +0.0% | 0.00% | – |
| Q1 2016 | $70,000 | -40.2% | 130,694 | 0.0% | 0.00% | – |
| Q4 2015 | $117,000 | +11.4% | 130,694 | +0.0% | 0.00% | – |
| Q3 2015 | $105,000 | -74.3% | 130,635 | -3.7% | 0.00% | – |
| Q2 2015 | $408,000 | +13500.0% | 135,676 | +9549.8% | 0.00% | – |
| Q1 2015 | $3,000 | -95.2% | 1,406 | -94.4% | 0.00% | – |
| Q4 2014 | $63,000 | -76.4% | 25,130 | -33.4% | 0.00% | – |
| Q3 2014 | $267,000 | +47.5% | 37,734 | +35.6% | 0.00% | – |
| Q2 2014 | $181,000 | -30.4% | 27,832 | -29.6% | 0.00% | – |
| Q1 2014 | $260,000 | +266.2% | 39,507 | +159.5% | 0.00% | – |
| Q4 2013 | $71,000 | -85.4% | 15,224 | -84.5% | 0.00% | – |
| Q3 2013 | $486,000 | – | 98,448 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
| BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
| NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
| Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
| Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
| Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
| Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
| Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |